Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 14/20 | 0.67 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5487405 | 0.98 | ACHE (0.65) | ACHEEPHX1 | |
| SCHEMBL25051834 | 0.93 | ACHE (0.73) | ACHEEPHX1 | |
| SCHEMBL856878 | 0.91 | ACHE (0.70) | ACHE | |
| SCHEMBL6269354 | 0.89 | ACHE (0.68) | ACHEEPHX1 | |
| SCHEMBL3902756 | 0.88 | ACHE (0.59) | ACHEALDH1A1 | |
| SCHEMBL7677452 | 0.87 | ACHE (0.71) | ACHEEPHX1 | |
| SCHEMBL4736241 | 0.87 | ACHE (0.71) | ACHEEPHX1 | |
| SCHEMBL6950987 | 0.87 | ACHE (0.71) | ACHEEPHX1 | |
| SCHEMBL721691 | 0.87 | ACHE (0.71) | ACHEEPHX1 | |
| SCHEMBL29991047 | 0.87 | ACHE (0.71) | ACHEEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110000905-A | A kind of heat-barrier material, hot runner plastic injection mould and Shooting Technique | 蓝思科技（长沙）有限公司 | 2019-07-12 | — | — | CN | claimed |
| WO-2025264905-A1 | CARBORANE-BASED BORON-ENRICHED PEG LINKERS FOR MAB LIGATION SYNTHESIS AND METHODS | TAE LIFE SCIENCES LLC (US) | 2025-12-26 | — | — | WO | disclosed |
| WO-2024206663-A1 | REACTIVE CAPSID PROTEIN ASSOCIATED MOLECULES | THE TRUSTEES OF INDIANA UNIVERSITY (US) | 2024-10-03 | — | — | WO | disclosed |
| WO-2023135265-A1 | MOLECULES TARGETING VIRAL RNA AND/OR VIRAL RNA-PROTEIN COMPLEXES FOR USE IN THE TREATMENT OF VIRAL INFECTIONS, IN PARTICULAR COVID-19 | Johann Wolfgang Goethe-Universität Frankfurt am Main (DE) | 2023-07-20 | — | — | WO | disclosed |
| US-20230114728-A1 | PENICILLIN-BINDING PROTEIN INHIBITORS | VenatoRx Pharmaceuticals, Inc. | 2023-04-13 | — | — | US | disclosed |
| US-20230069963-A1 | PYRAZOLO[1,5-A]PYRIMIDINE MACROCYCLIC COMPOUND | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2023-03-09 | — | — | US | disclosed |
| EP-4097116-A1 | INTERCELLULAR AND INTRACELLULAR PROXIMITY-BASED LABELING COMPOSITIONS AND SYSTEMS | The Trustees of Princeton University (US) | 2022-12-07 | — | — | EP | disclosed |
| CN-112979509-B | Trifluoromethanesulfonyl alkynamide compound and preparation method and application thereof | 江西师范大学 | 2022-04-22 | — | — | CN | disclosed |
| CN-109906227-B | 8, 9-dihydroimidazo [1,2-a ] pyrimido [5,4-e ] pyrimidin-5 (6H) -ones | 上海瑛派药业有限公司 | 2022-03-11 | — | — | CN | disclosed |
| US-11092594-B2 | Haptens, hapten conjugates, compositions thereof and method for their preparation and use | VENTANA MEDICAL SYSTEMS, INC. (US) | 2021-08-17 | — | — | US | disclosed |
| WO-1997032844-A9 | HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | — | 1997-12-24 | — | — | WO | disclosed |
| WO-1997043289-A1 | LARGE SYNTHETIC COMPOUNDS BASED ON ELECTRON DONOR AND ELECTRON ACCEPTOR INTERACTIONS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1997-11-20 | — | — | WO | disclosed |
| WO-1997032844-A1 | HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | G.D. SEARLE & CO. (US) | 1997-09-12 | — | — | WO | disclosed |
| EP-0788376-A2 | CALIXARENE CONJUGATES USEFUL AS MRI AND CT DIAGNOSTIC IMAGING AGENTS | MOLECULAR BIOSYSTEMS, INC. (US) | 1997-08-13 | — | — | EP | disclosed |
| US-5581002-A | BLOCKING WITH BUTYLDIMETHYLSILANYL CHLORIDE; ALKYLATION; OZONOLYZING WITH SODIUM HYPOCHLORITE; DEBLOCKING | ABBOTT LABORATORIES (US) | 1996-12-03 | — | — | US | disclosed |
| US-5559210-A | STEROIDS AS IMMUNOGENS | ABBOTT LABORATORIES (US) | 1996-09-24 | — | — | US | disclosed |
| WO-1996014878-A2 | CALIXARENE CONJUGATES USEFUL AS MRI AND CT DIAGNOSTIC IMAGING AGENTS | MOLECULAR BIOSYSTEMS, INC. (US) | 1996-05-23 | — | — | WO | disclosed |
| EP-0712497-A1 | REAGENTS AND METHODS FOR THE DETECTION AND QUANTIFICATION OF TESTOSTERONE IN FLUID SAMPLES | Abbott Laboratories (US) | 1996-05-22 | — | — | EP | disclosed |
| US-5491071-A | LABELS; TEST KITS; IMMUNOASSAYS | ABBOTT LABORATORIES (US) | 1996-02-13 | — | — | US | disclosed |
| WO-1995004283-A1 | REAGENTS AND METHODS FOR THE DETECTION AND QUANTIFICATION OF TESTOSTERONE IN FLUID SAMPLES | ABBOTT LABORATORIES (US) | 1995-02-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230069963-A1 | PYRAZOLO[1,5-A]PYRIMIDINE MACROCYCLIC COMPOUND | ZC3HAV1, ZC3HAV1L, IL5 | ACHE 4829/4885EPHX1 3935/4885ALDH1A1 2801/4885 |
| US-20230114728-A1 | PENICILLIN-BINDING PROTEIN INHIBITORS | PEPD, BPGM, EBPL | ACHE 479/4885EPHX1 4100/4885ALDH1A1 2794/4885 |
| US-11092594-B2 | Haptens, hapten conjugates, compositions thereof and method for their preparation and use | CRBN, AHR, RORB | ACHE 731/4885EPHX1 3045/4885ALDH1A1 2734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.